How would you manage a patient with high risk prostate cancer with rising PSA after RP who has oligometastatic bone disease in the pelvis?

1 Answers

Mednet Member

Radiation Oncology · Varian Medical Systems/Allegheny health network

For now, the standard of care is systemic treatment of which the type is sometimes driven by extent of bony disease.